Gentex Corporation (GNTX) Key Metrics
GNTX valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $4.43B
- Enterprise value
- $4.46B
- P/E (TTM)
- 11.1 10-yr median 16.9
- Forward P/E
- 10.1
- PEG ratio
- 0.66
- Price / sales
- 1.7 10-yr median 3.3
- Price / book
- 1.9 10-yr median 3.0
- EV / EBITDA
- 7.2 10-yr median 11.4
- Dividend yield
- 2.28% $0.48 a year
- Beta
- 0.85
GNTX key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsGNTX valuation Price multiples at each fiscal year-end price.
GNTX returns How much profit the business earns on the capital it uses.
GNTX per-share figures Results divided by the shares outstanding at year-end.
GNTX financial health Debt, liquidity and how easily interest is covered.
GNTX efficiency & capital use Working capital cycle and where the cash goes.
GNTX valuation history
GNTX returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
GNTX debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
GNTX cash returned to shareholders
GNTX price vs earnings per share
GNTX key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $5.11B | $6.49B | $7.50B | $6.31B | $8.25B | $8.27B | $7.34B | $5.45B | $6.04B | $5.73B |
| Enterprise value | $4.96B | $6.24B | $7.27B | $6.06B | $7.98B | $7.90B | $6.90B | $5.07B | $5.39B | $5.19B |
| P/E ratio | 13.3 | 16.1 | 17.5 | 19.8 | 22.9 | 23.8 | 17.3 | 12.5 | 14.8 | 16.5 |
| Price / sales | 2.0 | 2.8 | 3.3 | 3.3 | 4.8 | 4.9 | 3.9 | 3.0 | 3.4 | 3.4 |
| Price / book | 2.1 | 2.6 | 3.2 | 3.1 | 4.3 | 4.2 | 3.8 | 2.9 | 2.9 | 3.0 |
| Price / free cash flow | 11.2 | 18.4 | 21.2 | 32.9 | 28.1 | 20.0 | 17.4 | 11.7 | 15.2 | 16.4 |
| Price / operating cash flow | 8.7 | 13.0 | 14.0 | 18.6 | 22.8 | 17.8 | 14.5 | 9.9 | 12.1 | 12.2 |
| EV / sales | 2.0 | 2.7 | 3.2 | 3.2 | 4.6 | 4.7 | 3.7 | 2.8 | 3.0 | 3.1 |
| EV / EBITDA | 8.8 | 11.1 | 12.1 | 13.0 | 15.5 | 15.7 | 11.6 | 8.3 | 8.7 | 8.7 |
| EV / free cash flow | 10.8 | 17.7 | 20.5 | 31.6 | 27.2 | 19.1 | 16.4 | 10.9 | 13.6 | 14.8 |
| Earnings yield | 7.5% | 6.2% | 5.7% | 5.1% | 4.4% | 4.2% | 5.8% | 8.0% | 6.7% | 6.1% |
| Free cash flow yield | 9.0% | 5.4% | 4.7% | 3.0% | 3.6% | 5.0% | 5.7% | 8.6% | 6.6% | 6.1% |
| Dividend yield | 2.1% | 1.7% | 1.5% | 1.8% | 1.4% | 1.4% | 1.6% | 2.1% | 1.8% | 1.8% |
| Shareholder yield (dividends + buybacks) | 8.3% | 4.9% | 3.5% | 3.6% | 5.3% | 4.9% | 6.1% | 13.0% | 5.6% | 4.6% |
| Share price at fiscal year-end | $23.27 | $28.73 | $32.66 | $27.27 | $34.85 | $33.93 | $28.98 | $20.21 | $20.95 | $19.69 |
| Per share | ||||||||||
| Revenue per share | $11.55 | $10.23 | $10.01 | $8.30 | $7.32 | $6.93 | $7.34 | $6.80 | $6.23 | $5.77 |
| Earnings per share | $1.75 | $1.79 | $1.86 | $1.38 | $1.52 | $1.43 | $1.68 | $1.62 | $1.41 | $1.19 |
| Operating cash flow per share | $2.67 | $2.20 | $2.34 | $1.46 | $1.53 | $1.91 | $2.00 | $2.05 | $1.74 | $1.62 |
| Free cash flow per share | $2.09 | $1.56 | $1.54 | $0.83 | $1.24 | $1.69 | $1.66 | $1.73 | $1.38 | $1.20 |
| Cash per share | $0.69 | $1.13 | $1.05 | $1.05 | $1.13 | $1.85 | $1.72 | $1.43 | $2.51 | $2.49 |
| Book value per share | $11.33 | $10.92 | $10.07 | $8.93 | $8.19 | $8.06 | $7.65 | $6.90 | $7.11 | $6.56 |
| Tangible book value per share | $8.84 | $8.25 | $7.65 | $6.63 | $5.71 | $5.75 | $5.45 | $4.68 | $4.97 | $4.37 |
| Dividends per share | $0.49 | $0.49 | $0.49 | $0.49 | $0.49 | $0.48 | $0.46 | $0.43 | $0.38 | $0.35 |
| Capex per share | $0.59 | $0.64 | $0.80 | $0.63 | $0.29 | $0.21 | $0.33 | $0.32 | $0.36 | $0.42 |
| Debt per share | $0.02 | $0.02 | $0.02 | — | — | $0.32 | — | — | $0.27 | $0.64 |
| Shares outstanding | 219.5M | 226.0M | 229.7M | 231.2M | 236.6M | 243.7M | 253.3M | 269.9M | 288.2M | 291.1M |
| Change in shares outstanding | −2.9% | −1.6% | −0.6% | −2.3% | −2.9% | −3.8% | −6.2% | −6.4% | −1.0% | −1.7% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | 15.5% | 16.9% | 19.6% | 15.9% | 18.5% | 17.8% | 22.4% | 22.4% | 20.5% | 19.1% |
| Return on invested capital (ROIC) | 17.8% | 18.3% | 21.6% | 18.3% | 21.8% | 21.8% | 27.9% | 29.6% | 28.8% | 25.1% |
| Return on assets (ROA) | 13.5% | 14.9% | 16.9% | 14.1% | 16.6% | 15.8% | 19.9% | 19.7% | 17.5% | 15.6% |
| Return on tangible assets | 16.2% | 18.7% | 20.2% | 17.2% | 23.4% | 20.9% | 26.1% | 29.4% | 23.4% | 20.8% |
| Free cash flow margin | 18.1% | 15.3% | 15.4% | 10.0% | 16.9% | 24.5% | 22.7% | 25.4% | 22.1% | 20.9% |
| Income quality (OCF / net income) | 1.53 | 1.23 | 1.25 | 1.06 | 1.00 | 1.34 | 1.19 | 1.26 | 1.23 | 1.36 |
| Financial health | ||||||||||
| Total debt | $3.8M | $4.7M | $3.6M | — | — | $78.0M | — | — | $78.0M | $185.6M |
| Cash & short-term investments | $151.0M | $255.6M | $240.8M | $241.8M | $267.7M | $450.5M | $436.7M | $386.4M | $722.3M | $723.5M |
| Net debt | −$147.2M | −$250.9M | −$237.2M | −$241.8M | −$267.7M | −$372.5M | −$436.7M | −$386.4M | −$644.3M | −$537.9M |
| Debt / equity | 0.00 | 0.00 | 0.00 | — | — | 0.04 | — | — | 0.04 | 0.10 |
| Debt / assets | 0.00 | 0.00 | 0.00 | — | — | 0.04 | — | — | 0.03 | 0.08 |
| Net debt / EBITDA | −0.26 | −0.45 | −0.40 | −0.52 | −0.52 | −0.74 | −0.74 | −0.63 | −1.03 | −0.90 |
| Current ratio | 2.91 | 4.11 | 3.67 | 3.79 | 4.81 | 5.51 | 5.53 | 5.03 | 4.86 | 7.71 |
| Quick ratio | 1.58 | 2.38 | 2.19 | 2.17 | 3.06 | 4.24 | 4.08 | 3.70 | 3.97 | 6.44 |
| Interest coverage | — | — | — | 3.8 | 3.9 | 665.9 | 4.2 | — | — | — |
| Working capital | $740.9M | $784.6M | $726.1M | $698.1M | $691.3M | $801.6M | $778.5M | $681.8M | $940.9M | $1.01B |
| Invested capital | $2.34B | $2.22B | $2.08B | $1.82B | $1.67B | $1.59B | $1.50B | $1.48B | $1.41B | $1.37B |
| Tangible asset value | $1.94B | $1.87B | $1.76B | $1.53B | $1.35B | $1.40B | $1.38B | $1.25B | $1.42B | $1.27B |
| Net current asset value | $690.8M | $748.6M | $632.1M | $625.1M | $679.6M | $719.1M | $704.0M | $612.2M | $865.2M | $755.8M |
| Graham number | $21.15 | $20.97 | $20.55 | $16.65 | $16.76 | $16.08 | $16.99 | $15.87 | $15.03 | $13.28 |
| Graham net-net per share | $1.13 | $1.80 | $1.38 | $1.42 | $1.77 | $2.12 | $1.94 | $1.56 | $2.38 | $1.98 |
| Capital allocation | ||||||||||
| Dividends paid | $106.9M | $110.4M | $112.2M | $113.1M | $115.3M | $117.2M | $116.3M | $116.6M | $108.8M | $101.1M |
| Share buybacks (net) | $315.5M | $206.1M | $147.4M | $112.5M | $324.6M | $288.5M | $331.5M | $591.6M | $231.4M | $163.4M |
| Dividend payout ratio | 27.8% | 27.3% | 26.2% | 35.5% | 32.0% | 33.7% | 27.4% | 26.6% | 26.7% | 29.1% |
| Dividends + buybacks / free cash flow | 92.2% | 89.5% | 73.4% | 117.7% | 150.0% | 98.3% | 106.3% | 151.8% | 85.7% | 75.5% |
| Capex / revenue | 5.1% | 6.3% | 8.0% | 7.6% | 4.0% | 3.1% | 4.6% | 4.7% | 5.8% | 7.2% |
| Capex / operating cash flow | 22.0% | 29.0% | 34.2% | 43.3% | 19.0% | 11.1% | 16.7% | 15.6% | 20.8% | 25.7% |
| Capex / depreciation | 1.24 | 1.53 | 1.97 | 1.52 | 0.69 | 0.49 | 0.81 | 0.84 | 1.04 | 1.37 |
| Stock-based compensation / revenue | 1.4% | 1.7% | 1.7% | 1.6% | 1.6% | 1.8% | 1.2% | 1.0% | 1.0% | 1.1% |
| R&D / revenue | 8.0% | 7.8% | 6.7% | 6.9% | 6.8% | 6.9% | 6.2% | 5.8% | 5.6% | 5.6% |
| SG&A / revenue | 7.0% | 5.2% | 4.9% | 5.5% | 5.3% | 5.3% | 4.6% | 4.1% | 4.0% | 3.7% |
| Efficiency | ||||||||||
| Days sales outstanding | 47.8 | 48.7 | 47.5 | 50.1 | 56.4 | 56.3 | 44.1 | 44.2 | 45.0 | 44.3 |
| Days of inventory on hand | 104.3 | 99.3 | 95.8 | 100.5 | 89.1 | 80.1 | 73.9 | 70.5 | 67.4 | 65.7 |
| Days payables outstanding | 45.7 | 41.7 | 39.9 | 34.9 | 30.1 | 30.7 | 29.7 | 29.2 | 28.2 | 26.4 |
| Cash conversion cycle (days) | 106.4 | 106.2 | 103.4 | 115.6 | 115.4 | 105.6 | 88.3 | 85.6 | 84.2 | 83.6 |
| Receivables turnover | 7.63 | 7.50 | 7.69 | 7.29 | 6.48 | 6.49 | 8.28 | 8.25 | 8.11 | 8.24 |
| Payables turnover | 7.99 | 8.74 | 9.14 | 10.47 | 12.14 | 11.88 | 12.30 | 12.52 | 12.96 | 13.81 |
| Inventory turnover | 3.50 | 3.68 | 3.81 | 3.63 | 4.10 | 4.56 | 4.94 | 5.17 | 5.42 | 5.55 |
| Asset turnover | 0.89 | 0.85 | 0.91 | 0.85 | 0.79 | 0.77 | 0.87 | 0.83 | 0.77 | 0.75 |
| Average receivables | $331.9M | $308.6M | $299.2M | $263.1M | $267.4M | $260.2M | $224.5M | $222.3M | $221.4M | $203.8M |
| Average payables | $208.6M | $176.4M | $168.1M | $125.0M | $91.6M | $91.2M | $95.2M | $91.4M | $84.9M | $73.2M |
| Average inventory | $476.4M | $419.5M | $403.4M | $360.3M | $271.3M | $237.6M | $237.1M | $221.0M | $203.0M | $182.0M |
| Intangibles / total assets | 18.7% | 21.8% | 20.7% | 22.3% | 27.5% | 25.3% | 25.5% | 28.7% | 26.2% | 27.7% |
Computed from GNTX's annual financial statements (latest annual report filed February 24, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
GNTX valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), Gentex traded at 13.3 times earnings, against a 10-year median of 16.9. Based on the latest twelve months, the trailing P/E is 11.1 and the forward P/E is 10.1. Gentex earned a return on equity of 15.5% and a return on invested capital of 17.8% in fiscal 2025. It ended the year with $3.8 million of debt and $151.0 million in cash and short-term investments, a net cash position of $147.2 million. It returned $422.4 million to shareholders: $106.9 million in dividends and $315.5 million in share buybacks, 92% of free cash flow. The share count fell 24.6% from 291.1M to 219.5M over 9 years.
See the GNTX income statement, the GNTX chart for price history, or the GNTX stock overview for the latest quote and news.
GNTX key metrics FAQ
What is Gentex's P/E ratio?
Gentex's trailing P/E ratio is 11.1 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 10.1. At the end of fiscal 2025 it was 13.3, compared with a 10-year median of 16.9.
What is Gentex's EV/EBITDA?
Gentex's enterprise value was 8.8 times EBITDA at the end of fiscal 2025 (enterprise value $5.0 billion, EBITDA $565.1 million); the current EV/EBITDA is 7.2.
What is Gentex's return on equity?
Gentex's return on equity (ROE) was 15.5% in fiscal 2025: net income of $384.8 million on average shareholders' equity of $2.5 billion.
What is Gentex's ROIC?
Gentex's return on invested capital was 17.8% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Gentex have?
Gentex had total debt of $3.8 million at the end of fiscal 2025, a debt-to-equity ratio of 0.00 and more cash than debt.
What is Gentex's dividend yield?
Gentex's forward dividend yield is 2.28%. Gentex paid $106.9 million in dividends in fiscal 2025 ($0.49 per share), a payout ratio of 27.8%.
Does Gentex buy back its shares?
Yes. Gentex spent $315.5 million on net share repurchases in fiscal 2025 Shares outstanding changed −2.9% over the year, to 219.5M..
What is Gentex's free cash flow yield?
Gentex generated $458.0 million of free cash flow in fiscal 2025, a free cash flow yield of 9.0% on its market value at year-end ($5.1 billion).
What is Gentex's current ratio?
Gentex's current ratio was 2.91 at the end of fiscal 2025: current assets were 2.91 times current liabilities.